-
1
-
-
0030689616
-
Evaluation of treatment-resistant schizophrenia
-
Conley RR, Buchanan RW: Evaluation of treatment-resistant schizophrenia. Schizophr Bull 1997; 23:663-674
-
(1997)
Schizophr Bull
, vol.23
, pp. 663-674
-
-
Conley, R.R.1
Buchanan, R.W.2
-
2
-
-
0014272053
-
High dose chlorpromazine therapy in chronic schizophrenia
-
Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Arch Gen Psychiatry 1968; 18:482-95
-
(1968)
Arch Gen Psychiatry
, vol.18
, pp. 482-495
-
-
Prien, R.F.1
Cole, J.O.2
-
3
-
-
0017644231
-
Antipsychotic drugs: Clinical pharmacology and therapeutic use
-
Davis JM, Casper R: Antipsychotic drugs: clinical pharmacology and therapeutic use. Drugs 1977; 12:260-282
-
(1977)
Drugs
, vol.12
, pp. 260-282
-
-
Davis, J.M.1
Casper, R.2
-
4
-
-
0029925213
-
Clozapine eligibility among state hospital patients
-
Essock SM, Hargreaves W A, Dohm FA, Goethe J, Carver L, Hipshman L: Clozapine eligibility among state hospital patients. Schizophr Bull 1996; 22:15-25
-
(1996)
Schizophr Bull
, vol.22
, pp. 15-25
-
-
Essock, S.M.1
Hargreaves, W.A.2
Dohm, F.A.3
Goethe, J.4
Carver, L.5
Hipshman, L.6
-
5
-
-
0024242021
-
A selective review of recent North American long-term followup studies of schizophrenia
-
McGlashan TH: A selective review of recent North American long-term followup studies of schizophrenia. Schizophr Bull 1988; 14:515-542
-
(1988)
Schizophr Bull
, vol.14
, pp. 515-542
-
-
McGlashan, T.H.1
-
6
-
-
0024995710
-
Economic grand rounds: Cost-effectiveness of clozapine for treatment-resistant schizophrenic patients
-
Revicki DA, Luce BR, Weschler JM, Brown RE, Adler MA: Economic grand rounds: cost-effectiveness of clozapine for treatment-resistant schizophrenic patients. Hosp Community Psychiatry 1990; 41:850-854
-
(1990)
Hosp Community Psychiatry
, vol.41
, pp. 850-854
-
-
Revicki, D.A.1
Luce, B.R.2
Weschler, J.M.3
Brown, R.E.4
Adler, M.A.5
-
7
-
-
0025938251
-
When symptoms persist: Choosing among alternative somatic treatments for schizophrenia
-
Christison GW, Kirch DG, Wyatt RJ: When symptoms persist: choosing among alternative somatic treatments for schizophrenia. Schizophr Bull 1991; 17:217-245
-
(1991)
Schizophr Bull
, vol.17
, pp. 217-245
-
-
Christison, G.W.1
Kirch, D.G.2
Wyatt, R.J.3
-
8
-
-
0029989771
-
Pharmacological treatment strategies in the non-responsive schizophrenic patient
-
Barnes TRE, McEvedy CJB: Pharmacological treatment strategies in the non-responsive schizophrenic patient. Int Clin Psychopharmacol 1996; 11:67-71
-
(1996)
Int Clin Psychopharmacol
, vol.11
, pp. 67-71
-
-
Barnes, T.R.E.1
McEvedy, C.J.B.2
-
9
-
-
0023812652
-
Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine
-
Kane J, Honigfeld G, Singer J, Meltzer H, Clozaril Collaborative Study Group: Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789-796
-
(1988)
Arch Gen Psychiatry
, vol.45
, pp. 789-796
-
-
Kane, J.1
Honigfeld, G.2
Singer, J.3
Meltzer, H.4
-
10
-
-
0026772116
-
Clinical and biologic response to clozapine in patients with schizophrenia: Crossover comparison with fluphenazine
-
Pickar D, Owen RR, Litman RE, Konicki E, Gutierrez R, Rapaport MH: Clinical and biologic response to clozapine in patients with schizophrenia: crossover comparison with fluphenazine. Arch Gen Psychiatry 1992; 49:345-353
-
(1992)
Arch Gen Psychiatry
, vol.49
, pp. 345-353
-
-
Pickar, D.1
Owen, R.R.2
Litman, R.E.3
Konicki, E.4
Gutierrez, R.5
Rapaport, M.H.6
-
11
-
-
0027972344
-
Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia
-
Breier A, Buchanan RW, Kirkpatrick B, Davis OR, Irish D, Summerfelt A, Carpenter WT Jr: Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994; 151:20-26
-
(1994)
Am J Psychiatry
, vol.151
, pp. 20-26
-
-
Breier, A.1
Buchanan, R.W.2
Kirkpatrick, B.3
Davis, O.R.4
Irish, D.5
Summerfelt, A.6
Carpenter Jr., W.T.7
-
13
-
-
0027452203
-
Treatment of neuroleptic-resistant schizophrenia relapse
-
Kinon BJ, Kane JM, Johns C, Perovich R, Ismi M, Koreen A, Weiden P: Treatment of neuroleptic-resistant schizophrenia relapse. Psychopharmacol Bull 1993; 29:309-314
-
(1993)
Psychopharmacol Bull
, vol.29
, pp. 309-314
-
-
Kinon, B.J.1
Kane, J.M.2
Johns, C.3
Perovich, R.4
Ismi, M.5
Koreen, A.6
Weiden, P.7
-
14
-
-
0029880065
-
Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha1-adrenergic and muscarinic receptors in vivo in rats
-
Bymaster FP, Hemrick-Luecke SK, Perry KW, Fuller RW: Neurochemical evidence for antagonism by olanzapine of dopamine, serotonin, alpha1-adrenergic and muscarinic receptors in vivo in rats. Psychopharmacology (Berl) 1996; 124:87-94
-
(1996)
Psychopharmacology (Berl)
, vol.124
, pp. 87-94
-
-
Bymaster, F.P.1
Hemrick-Luecke, S.K.2
Perry, K.W.3
Fuller, R.W.4
-
15
-
-
0030048254
-
Effects of olanzapine on regional Cfos expression in rat forebrain
-
Robertson GS, Fibiger HC: Effects of olanzapine on regional Cfos expression in rat forebrain. Neuropsychopharmacology 1996; 14:109-110
-
(1996)
Neuropsychopharmacology
, vol.14
, pp. 109-110
-
-
Robertson, G.S.1
Fibiger, H.C.2
-
16
-
-
0030993030
-
Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: Results of an international collaborative trial
-
Tollefson GD, Beasley CM Jr, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME: Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. Am J Psychiatry 1997; 154:457-465
-
(1997)
Am J Psychiatry
, vol.154
, pp. 457-465
-
-
Tollefson, G.D.1
Beasley Jr., C.M.2
Tran, P.V.3
Street, J.S.4
Krueger, J.A.5
Tamura, R.N.6
Graffeo, K.A.7
Thieme, M.E.8
-
17
-
-
0016633519
-
Ciozapine: A new and unusual antipsychotic agent
-
Simpson GM, Varga E: Ciozapine: a new and unusual antipsychotic agent. Psychopharmacol Bull 1975; 11:14-15
-
(1975)
Psychopharmacol Bull
, vol.11
, pp. 14-15
-
-
Simpson, G.M.1
Varga, E.2
-
18
-
-
0003400240
-
-
New York, New York State Psychiatric Institute, Biometrics Research
-
Spitzer RL, Williams JBW, Gibbon M: Structured Clinical Interview for DSM-III-R (SCID). New York, New York State Psychiatric Institute, Biometrics Research, 1987
-
(1987)
Structured Clinical Interview for DSM-III-R (SCID)
-
-
Spitzer, R.L.1
Williams, J.B.W.2
Gibbon, M.3
-
19
-
-
0000503515
-
The Brief Psychiatric Rating Scale
-
Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 1962; 10:799-812
-
(1962)
Psychol Rep
, vol.10
, pp. 799-812
-
-
Overall, J.E.1
Gorham, D.R.2
-
20
-
-
0003412410
-
-
Rockville, Md, US Department of Health, Education, and Welfare
-
Guy W (ed): ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338. Rockville, Md, US Department of Health, Education, and Welfare, 1976, pp 217-222
-
(1976)
ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76-338
, pp. 217-222
-
-
Guy, W.1
-
24
-
-
0024358369
-
A rating scale for drug-induced akathisia
-
Barnes TR: A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154:672-676
-
(1989)
Br J Psychiatry
, vol.154
, pp. 672-676
-
-
Barnes, T.R.1
-
26
-
-
0028007550
-
Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome
-
Lieberman JA, Safferman AZ, Pollack S, Szymanski S, Johns C, Howard A, Kronig M, Bookstein P, Kane JM: Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome. Am J Psychiatry 1994; 151:1744-1752
-
(1994)
Am J Psychiatry
, vol.151
, pp. 1744-1752
-
-
Lieberman, J.A.1
Safferman, A.Z.2
Pollack, S.3
Szymanski, S.4
Johns, C.5
Howard, A.6
Kronig, M.7
Bookstein, P.8
Kane, J.M.9
|